Merck Aims to Double R&D Productivity in Oncology, Neurology and Immunology to Deliver More…
Merck, a leading science and technology company, shared updates on the company’s healthcare research and development strategy, aimed at doubling…
Browsing Tag
Oncology
SpIntellx and iCura Diagnostics Partner to Expand Access to Advanced Spatial Analytics and…
SpIntellx, Inc., a leader in spatially intelligent biology, and iCura Diagnostics, a leading contract research organization (CRO) focused on…
VeriSIM Life Enters into Collaboration Agreement with Mayo Clinic to Jointly Advance Drug Discovery…
VeriSIM Life (VeriSIM), a leading artificial intelligence (AI)-enabled company providing services to de-risk R&D decision making for breakthrough…
Aqemia Announces an Extension of Its First Collaboration With Sanofi About AI and Quantum…
Aqemia, the next-gen pharmatech company leveraging artificial intelligence and quantum physics announced, that it has entered a new research…
GE Healthcare Advances the Future of Precision Medicine in Oncology with New Technology Partners at…
Collaborations demonstrate role as a core partner in multidisciplinary cancer care
From early detection to remote monitoring and data…
Median Technologies Launches Imaging Lab, Spearheading the Integration of iBiopsy Artificial…
With Imaging Lab, Median will provide biopharmaceutical companies with new decision-making tools for clinical trials by leveraging images with…
Endeavor BioMedicines Partners with xCures to Identify Patients with PTCH1 Mutations for Phase 2…
xCures to use tumor sequencing information and its platform to pair patients with available treatment options
Endeavor BioMedicines, a…
Ontada Research Highlights Power of Real-World Oncology Data at ISPOR 2022
Studies Show the Ability of Real-World Oncology Evidence to Generate Insights into Treatment Effectiveness and Patient Outcomes
Ontada, a …
Guardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in…
Blood-based multimodal test achieved 100% sensitivity for colorectal cancer at 90% specificity in a prospective study of 557 individuals
Guardant…
Guardant Health Announces Partnership with Epic to Streamline Access to Company’s Broad Portfolio of…
Partnership will Make Guardant Health Cancer Tests Available to Over 250 Million Patients with a Record in Epic
Integration Will…